A New Measure of Success for Your Premium IOL Patients
Introducing ClearView™ 3
The next-generation asymmetric multifocal refractive IOL now
FDA approved and available in the United States.
ClearView™ 3 is a rotationally asymmetric MIOL designed to improve contrast sensitivity, minimize halos and glare and provide superior near, intermediate and far vision compared to other presbyopic IOLs
The segmented optic design is the first of its kind in the US. Lenstec’s patented four-point fixation and design allows surgeons confidence in the IOLs effective lens position within the capsule. Its availability in 0.25 diopter power increments, along with the tightest industry tolerances (+/- 0.11 diopters from labelled power), assists surgeons in achieving the best refractive outcomes possible.